Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
August 2015
|
| In: |
Clinical lymphoma, myeloma & leukemia
Year: 2015, Volume: 15, Issue: 8, Pages: 458-463 |
| ISSN: | 2152-2669 |
| DOI: | 10.1016/j.clml.2015.03.008 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.clml.2015.03.008 |
| Author Notes: | Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho, Mathias Witzens-Harig |
| Item Description: | Gesehen am 19.01.2017 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2152-2669 |
| DOI: | 10.1016/j.clml.2015.03.008 |